Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 32060 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 38119 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 43147 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 46170 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 56141 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 57511 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 61073 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 61558 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 64051 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 66908 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 70184 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 72296 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 74607 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 76655 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 79207 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 81268 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 81989 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 84298 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 90175 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 98887 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 99681 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 100274 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 100630 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 100785 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 104256 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 104309 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 106151 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 108212 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 108565 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 110824 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 111848 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 122098 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 123871 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 124109 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 124881 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 125763 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 126391 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 127824 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 129425 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 131254 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 137887 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 139703 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 141443 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 141647 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 142490 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 144711 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 145349 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 150447 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 154280 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 154594 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 156661 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 156905 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 157025 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 158890 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 160330 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 160992 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 161365 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 161430 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 163180 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 163748 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 164410 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 166616 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 169292 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 170789 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 182207 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 186757 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 188573 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 188918 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 190661 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 193672 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 198330 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 204934 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 209996 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 212166 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 212516 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 218848 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 219116 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 223901 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 229644 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 232758 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 236612 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 240435 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 242236 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 242856 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 244396 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 247512 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 249328 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 249598 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 251050 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 251252 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 254705 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 255712 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 262857 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 267779 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 269529 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 269846 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 274337 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 280204 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 280640 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 282544 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 286121 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 288176 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 288439 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 292195 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 292694 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 293499 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 297510 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 307168 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 310256 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 313598 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 315620 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 323174 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 323262 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 323262 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 323856 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 323888 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 324973 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 332050 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 345434 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 345452 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 349906 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 363522 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 363978 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 364328 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 368503 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 381048 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 394242 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 395641 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 404938 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 407995 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 409454 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 410547 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 412162 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 412484 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 412799 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 414827 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 420210 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 422486 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 432840 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 435052 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 436650 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 441544 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 451414 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 455528 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 462028 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 464556 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 474268 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 477052 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 480824 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 486879 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 489111 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 494437 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 507336 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 510268 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 512007 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 514012 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 524771 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 526456 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 541782 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 572622 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 579831 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 590358 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 611210 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 611777 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 623340 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 623580 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 637191 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 637386 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 661944 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 673465 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 674988 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 680239 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 684749 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 688809 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 696333 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 708953 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 709930 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 734188 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 753386 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 760116 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 762234 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 763611 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 765585 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 773876 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 782560 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 788823 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 795817 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 796811 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 801064 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 803990 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 824130 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 853571 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 857581 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 867474 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 878172 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 885024 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 896980 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 910968 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 920851 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | DOCOSAHEXAENOIC ACID (M-H)- | 960843 | Peak area normalized | No | PAH | Female | Cath |
Return to search page